Clinical trials
Carcinoma, Transitional Cell trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2017 | 9 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 11 |
| Terminated | 9 |
| Active, not recruiting | 4 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Daiichi Sankyo | 3 |
| EMD Serono Research & Development Institute, Inc. | 3 |
| Eli Lilly and Company | 3 |
| Incyte Corporation | 3 |
| Bayer | 2 |
| Exelixis | 2 |
| Hoffmann-La Roche | 2 |
| AIO-Studien-gGmbH | 1 |
| Achieve Life Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 45 |
| Urinary Bladder Neoplasms | 18 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Carcinoma, Renal Cell | 8 |
| Melanoma | 6 |
| Ovarian Neoplasms | 6 |
| Squamous Cell Carcinoma of Head and Neck | 6 |
| Neoplasm Metastasis | 5 |
| Colorectal Neoplasms | 4 |
| Urethral Neoplasms | 4 |
Trials
Showing 51 to 45 of 45. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.